Angiocrine Bioscience

San Diego, CA · Founded 2012 · Privately Held (backing)

Developer of a curative cellular therapies platform designed to treat indications in regenerative medicine and hematopoietic stem cell gene therapy. Angiocrine Bioscience is based in San Diego, CA and was founded in 2012. It was valued at $25.1 million at its later-stage round in Sep 2025, the last priced event on record. It has raised $88.8 million across 2 recorded rounds; the latest was a $2.1 million seed round in Aug 2025.

PMV mark · valuation
$25.1M
Oct 2026
Priced at
its later-stage round
Sep 2025
Total raised
$88.8M
Last round
Seed Round
Aug 2025
How much has Angiocrine Bioscience raised?
$88.8Macross 2 recorded rounds · Oct 2021 – Aug 2025

Most recently, Angiocrine Bioscience raised $2.1M in its Seed Round (Aug 2025).

Free account
More of Angiocrine Bioscience with a free account
  • ·Watch Angiocrine Bioscience: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Angiocrine Bioscience round by round

2 rounds
Aug 2025Seed Round$2.1MSEC filing▮
16 investors participated
Oct 2021Later Stage VC$58.1MSEC filing▮
78 investors participated

How much has Angiocrine Bioscience raised?

Angiocrine Bioscience has raised $88.8 million in total; 2 of its rounds are on record. The largest on record was a $58.1 million later-stage round in Oct 2021; the most recent was a $2.1 million seed round in Aug 2025.

Angiocrine Bioscience has filed 2 Form Ds with the SEC since 2021, most recently in Sep 2025 ($2.1 million sold to 16 investors).

Angiocrine Bioscience investors

7 investors are on record for Angiocrine Bioscience, including Good Growth Capital, Dubin & Co., Axil Capital Partners and California Institute for Regenerative Medicine. The seed round in Aug 2025 drew 16 investors.

For fundraisers
Raising for a company like Angiocrine Bioscience?

7 investors have backed Angiocrine Bioscience.

See all 7 investors →

Frequently asked about Angiocrine Bioscience

How much has Angiocrine Bioscience raised?
Angiocrine Bioscience has raised $88.8M in total across 2 recorded funding rounds.
When was Angiocrine Bioscience's last funding round?
Angiocrine Bioscience's most recent recorded round was Seed Round in Aug 2025, raising $2.1M.